close

Enter

Log in using OpenID

Iv Equipment Market to Record a Sluggish CAGR of 5.0% through 2017-2022

embed
An ageing population suffering from chronic diseases, particularly in developed regions, is anticipated to demand ever-more surgical procedures. IV therapy is one of the best choices available and this should benefit companies in the IV equipment m
Rising cases of needle stick injuries, the shift in demand towards ambulatory surgical
centers and fusion pumps, and a greater number of surgical procedures performed are
poised to benefit the IV equipment market. Furthermore, a prevalence of chronic
diseases in an ageing population in developed nations are positive signs for the IV
equipment market. However, lack of wireless connectivity, regulatory mandates for
new product launches and increasing cases of medication errors inhibit the
unencumbered growth of the IV equipment market that is anticipated to witness a
steady CAGR of 5% from 2017 to 2022.
An ageing population suffering from chronic diseases, particularly in developed
regions, is anticipated to demand ever-more surgical procedures. IV therapy is one of
the best choices available and this should benefit companies in the IV equipment
market. Strong economic growth in Latin America and APEJ are expected to provide
significant growth opportunities for companies actively involved in the IV equipment
market. Nonetheless, rising prevalence of medication errors, strict regulatory
requirements for new equipment and the absence of wireless connectivity in surgical
centers and hospitals could stifle the growth in the IV equipment market.
The IV catheter segment is the most popular in the IV equipment market and should
remain so for the foreseeable future. The IV catheter segment is expected to be worth
more than US$ 2.7 billion in 2017 itself and companies are recommended to target
this segment with gusto.The securement device segment and stopclocks & valve
segment have single digit revenue share in the IV equipment market. While the
former is projected to lose market share, the latter is on track to gain share and
companies may seek to take advantage of this. The drip chamber and needleless
connector segment have a revenue share of less than a tenth in the IV equipment
market at the end of 2017. The needleless connector segment is predicted to lose
substantial share in the near future while the drip chamber segment should fall
slowly.
The IV catheter segment accounted for a revenue share approaching one-third of the
IV equipment market by product type in 2017 and may gain market share going
forward. The IV catheter segment is poised to be worth just under US$ 3.5 billion at
the end of the forecast period in 2022, making it large enough for all stakeholders in
the IV equipment market. Infusion pumps follow IV catheters in the IV equipment
market and have a revenue share of approx. a sixth in terms of product type segment.
Europe is the largest region in the infusion pumps market as the continent has a welldeveloped medical infrastructure coupled with a geriatric population that would
naturally demand such treatment.
Europe is the largest region in the hospital segment of the IV equipment market but
there is a close competition for the second place between APEJ and North America.
The companies profiled in the IV equipment market are AngioDynamics, Moog Inc.,
Terumo Corporation, C. R. Bard, ICU Medical, Smiths Group, Baxter
International Inc., Fresenius SE & Co., B. Braun Melsungen AG, and Becton,
Dickinson and Company.
Request sample report @
https://www.persistencemarketresearch.com/samples/19297
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research
model is a unique collaboration of data analytics and market research methodology to
help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a
multi-disciplinary approach. At PMR, we unite various data streams from multidimensional sources. By deploying real-time data collection, big data, and customer
experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com
1/--pages
Report inappropriate content